converting from semaglutide to tirzepatide transitioning transitioning from semaglutide to tirzepatide dosing Tirzepatide (MOUNJARO®/ZEPBOUND) vs Semaglutide (OZEMPIC®/WEGOVY®) Switching From Semaglutide to Tirzepatide

Backed by science and designed to help you achieve sustainable weight loss, our program is tailored to meet your individual needs and goals

Both pathways require the active ingredient to be an FDA-approved drug or on the official bulk substances list

Hormonal changes in perimenopause and menopause Perimenopause (typically 40-50): Estrogen fluctuations (up and down unpredictably) Progesterone decline begins Growth hormone (GH) production dropping Testosterone declining (yes, women need it too) Irregular periods and cycles Menopause (average age 51): Estrogen drops dramatically Progesterone nearly absent GH continues declining Metabolic rate slows 20-30% End of menstrual cycles Post-menopause (50+): Low estrogen becomes new baseline Further GH decline Muscle loss accelerates (sarcopenia) Bone density concerns Continued metabolic challenges Learn about peptides in our what are peptides guide , how peptides work , and what are peptides used for

But it is where results often come from